Chronic Kidney Disease
Early diagnosis of CKD can slow eGFR decline
In this video from ASN Kidney Week, Navdeep Tangri, MD, PhD, discusses the results of the REVEAL CKD study.
‘Clear’ reduction in CV, renal outcomes with SGLT2 inhibitors across all high-risk groups
CHICAGO — A meta-analysis of 13 large SGLT2 inhibitor trials, including the recently published EMPA-KIDNEY trial, indicates that the drug class reduces CV and renal outcomes across all high-risk groups, with and without type 2 diabetes.
Social determinants of health influence risk, access to treatment of CKD
ORLANDO — A patient’s social determinants of health will influence access to chronic kidney disease screening and diagnosis and treatment of CKD, researchers reported here.
Empagliflozin lowers kidney disease progression, cardiovascular death in patients with CKD
ORLANDO —Empagliflozin reduced kidney disease progression and cardiovascular death in patients with chronic kidney disease, according to data presented at ASN Kidney Week.
Exclusion of race may lead to classification of living kidney donor as having CKD
ORLANDO —Use of the 2021 Chronic Kidney Disease Epidemiology Collaboration eGFR formula may lead to incorrect classification of Black living kidney donors as having CKD, according to data presented here.
Study shows no detrimental impact of continuing cardiac drugs with advanced CKD
ORLANDO — Patients with chronic kidney disease did not see a change in kidney function when clinicians continued a course of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, according to a study presented here.
President of ASN: The time for a nephrology movement is now
ORLANDO — Nephrology has never been better poised for a movement toward kidney health than now, according to the presidential address at ASN Kidney Week.
ASN Kidney Week expects more than 10,000 participants
The American Society of Nephrology is expecting more than 10,000 participants for Kidney Week in Orlando, Florida, this November, according to a press release.
Among patients with non-dialysis CKD, 83% report fatigue
Symptom prevalence ranged among patients with non-dialysis chronic kidney disease, with 24% reporting chest pain and 83% reporting fatigue, according to data published in the Clinical Journal of the American Society of Nephrology.
Panoramic Health launches clinical research division to improve kidney care outcomes
Panoramic Health announced the launch of Panoramic Science, its new clinical research division designed to improve kidney care innovation and outcomes, according to a press release.